Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
Progress in the treatment of acute myeloid leukaemia in adults
Author
Adrian Newland
Publication date
01-01-2002
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue Special Issue 1/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF03165254

Other articles of this Special Issue 1/2002

International Journal of Hematology 1/2002 Go to the issue

BriefCommunication

Current study of APL treatment in China

Standardization of Graft Engineering

Allogeneic peripheral blood stem cell versus bone marrow transplantations: CD34+ cell mobilisation, graft composition, immune reconstitution and clinical outcome

Immune and Cell Therapy for Hematological Disorders

Immune and cell therapy of hematologic malignancies

Current Status and Future Direction of International Registries

Goals and activities of the WMDA

Gene Therapy and Manipulation of Hematopoietic Stem Cell

Tumor specific targeting of adenoviral vectors to cancer

New Insight in Acquired Cytopenias

Immune pathophysiology of aplastic anemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits